These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19118701)

  • 1. I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.
    Boldt HC; Melia BM; Liu JC; Reynolds SM;
    Ophthalmology; 2009 Jan; 116(1):106-115.e1. PubMed ID: 19118701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
    McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
    Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
    Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
    Ophthalmology; 2020 Apr; 127(4S):S148-S157. PubMed ID: 32200815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
    Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
    Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
    Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
    Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
    Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
    Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
    Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
    Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.
    Diener-West M; Earle JD; Fine SL; Hawkins BS; Moy CS; Reynolds SM; Schachat AP; Straatsma BR;
    Arch Ophthalmol; 2001 Jul; 119(7):951-65. PubMed ID: 11448318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of central vision and macular structure in patients undergoing iodine-125 brachytherapy for ciliochoroidal melanoma.
    Oliver SC; Young TA; Kobe LH; Leu MY; Lee SP; Chun MW; Straatsma BR
    Am J Clin Oncol; 2008 Oct; 31(5):488-92. PubMed ID: 18838887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques.
    Lommatzsch PK; Alberti W; Lommatzsch R; Rohrwacher F
    Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):482-7. PubMed ID: 7926883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
    Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical choroidal neovascularization in radiation retinopathy.
    Spaide RF; Borodoker N; Shah V
    Am J Ophthalmol; 2002 May; 133(5):709-11. PubMed ID: 11992875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular complications following I-125 brachytherapy for choroidal melanoma.
    Wen JC; Oliver SC; McCannel TA
    Eye (Lond); 2009 Jun; 23(6):1254-68. PubMed ID: 19265865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe radiation retinopathy and optic neuropathy after brachytherapy for choroidal melanoma, treated by hyperbaric oxygen.
    Gall N; Leiba H; Handzel R; Pe'er J
    Eye (Lond); 2007 Jul; 21(7):1010-2. PubMed ID: 17435690
    [No Abstract]   [Full Text] [Related]  

  • 18. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY DETECTS SUBCLINICAL RADIAL PERIPAPILLARY CAPILLARY DENSITY REDUCTION AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA.
    Chien JL; Sioufi K; Ferenczy SR; Say EAT; Shields CL
    Retina; 2020 Sep; 40(9):1774-1782. PubMed ID: 31652197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE MACULA AFTER PLAQUE RADIOTHERAPY OF CHOROIDAL MELANOMA: Comparison of Irradiated Versus Nonirradiated Eyes in 65 Patients.
    Shields CL; Say EA; Samara WA; Khoo CT; Mashayekhi A; Shields JA
    Retina; 2016 Aug; 36(8):1493-505. PubMed ID: 26960015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.